Hyland Niall P, Sjöberg Frida, Tough Iain R, Herzog Herbert, Cox Helen M
Centre for Neuroscience Research, King's College London, GKT School of Biomedical Sciences, Guy's Campus, London SE1 1UL, UK.
Br J Pharmacol. 2003 Jun;139(4):863-71. doi: 10.1038/sj.bjp.0705298.
1 Neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) differentially activate three Y receptors (Y(1), Y(2) and Y(4)) in mouse and human isolated colon. 2 The aim of this study was to characterise Y(2) receptor-mediated responses in colon mucosa and longitudinal smooth muscle preparations from wild type (Y(2)+/+) and knockout (Y(2)-/-) mice and to compare the former with human mucosal Y agonist responses. Inhibition of mucosal short-circuit current and increases in muscle tone were monitored in colonic tissues from Y(2)+/+ and Y(2)-/- mice+/-Y(1) ((R)-N-[[4-(aminocarbonylaminomethyl)phenyl)methyl]-N(2)-(diphenylacetyl)-argininamide-trifluoroacetate (BIBO3304) or Y(2) (S)-N(2)-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamide (BIIE0246) antagonists. 3 Predictably, Y(2)-/- tissues were insensitive to Y(2)-preferred agonist PYY(3-36) (</=100 nM), but unexpectedly Y(4)-preferred PP responses were right-shifted probably as a consequence of elevated circulating PP levels, particularly in male Y(2)-/- mice (Sainsbury et al., 2002). 4 BIBO3304 and BIIE0246 elevated mucosal ion transport, indicating blockade of inhibitory mucosal tone in Y(2)+/+ tissue. While BIBO3304 effects were unchanged, those to BIIE0246 were absent in Y(2)-/- mucosae. Neither antagonist altered muscle tone; however, BIIE0246 blocked NPY and PYY(3-36) increases in Y(2)+/+ basal tone. BIBO3304 abolished residual Y(1)-mediated NPY responses in Y(2)-/- smooth muscle. 5 Tetrodotoxin significantly reduced BIIE0246 and PYY(3-36) effects in Y(2)+/+ mouse and human mucosae, but had no effect upon Y-agonist contractile responses, indicating that Y(2) receptors are located on submucosal, but not myenteric neurones. 6 Tonic activation of submucosal Y(2) receptors by endogenous NPY, PYY or PYY(3-36) could indirectly reduce mucosal ion transport in murine and human colon, while direct activation of Y(2) receptors on longitudinal muscle results in contraction.
1 神经肽Y(NPY)、肽YY(PYY)和胰多肽(PP)在小鼠和人离体结肠中对三种Y受体(Y(1)、Y(2)和Y(4))的激活作用存在差异。2 本研究的目的是表征野生型(Y(2)+/+)和基因敲除(Y(2)-/-)小鼠结肠黏膜和纵行平滑肌制剂中Y(2)受体介导的反应,并将前者与人类黏膜Y激动剂反应进行比较。在来自Y(2)+/+和Y(2)-/-小鼠的结肠组织中监测黏膜短路电流的抑制和肌张力的增加,这些组织±Y(1) ((R)-N-[[4-(氨基羰基氨基甲基)phenyl)甲基]-N(2)-(二苯基乙酰基)-精氨酰胺-三氟乙酸盐(BIBO3304)或Y(2) (S)-N(2)-[[1-[2-[4-[(R,S)-5,11-二氢-6(6H)-氧代二苯并[b,e]氮杂卓-11-基]-1-哌嗪基]-2-氧代乙基]环戊基]乙酰基]-N-[2-[1,2-二氢-3,5(4H)-二氧代-1,2-二苯基-3H-1,2,4-三唑-4-基]乙基]-精氨酰胺(BIIE0246)拮抗剂)。3 不出所料,Y(2)-/-组织对Y(2)偏好的激动剂PYY(3-36)(≤100 nM)不敏感,但出乎意料的是,Y(4)偏好的PP反应向右偏移,这可能是循环PP水平升高的结果,尤其是在雄性Y(2)-/-小鼠中(Sainsbury等人,2002年)。4 BIBO3304和BIIE0246提高了黏膜离子转运,表明在Y(2)+/+组织中抑制性黏膜张力被阻断。虽然BIBO3304的作用未改变,但在Y(2)-/-黏膜中对BIIE0246的作用不存在。两种拮抗剂均未改变肌张力;然而,BIIE0246阻断了Y(2)+/+基础肌张力中NPY和PYY(3-36)的增加。BIBO3304消除了Y(2)-/-平滑肌中残余的Y(1)介导的NPY反应。5 河豚毒素显著降低了Y(2)+/+小鼠和人黏膜中BIIE0246和PYY(3-36)的作用,但对Y激动剂的收缩反应没有影响,表明Y(